In some countries, this medicine may only be approved for veterinary use.
In the US, Danazol (danazol systemic) is a member of the drug class antigonadotropic agents and is used to treat Angioedema, Endometriosis, Evan's Syndrome and Fibrocystic Breast Disease.
US matches:
Scheme
Prop.INN
ATC (Anatomical Therapeutic Chemical Classification)
G03XA01
CAS registry number (Chemical Abstracts Service)
0017230-88-5
Chemical Formula
C22-H27-N-O2
Molecular Weight
337
Therapeutic Category
Gonadotropin inhibitor
Chemical Name
Pregna-2,4-dien-20-yno[2,3-d]isoxazol-17-ol, (17α)-
Foreign Names
- Danazolum (Latin)
- Danazol (German)
- Danazol (French)
- Danazol (Spanish)
Generic Names
- Danazol (OS: BAN, USAN, DCF, JAN)
- Danazolo (OS: DCIT)
- Win 17757 (IS)
- Danazol (PH: USP 32)
Brand Names
- Anargil
Medochemie, Bangladesh; Medochemie, Slovakia; Medochemie, Thailand; Medochemie, Vietnam
- Azol
Alphapharm, Australia; Alphapharm, Singapore; Merck, Indonesia; Pacific, New Zealand
- Benzol
Solitaire, India
- Bonzol
Tanabe Mitsubishi, Japan
- Cipladanogen
Biotoscana, Colombia
- Cyclolady
CCPC, Taiwan
- Cyclomen
sanofi-aventis, Canada
- Dainazol
Fuji Yakuhin, Japan
- Danamet
Eskayef, Bangladesh
- Danan
Towa Yakuhin, Japan
- Danarem
Remedica, Vietnam
- Danasin
Koçak, Turkey
- Danatrol
Sanofi-Aventis, Belgium; Sanofi-Aventis, Switzerland; Sanofi-Aventis, France; Sanofi-Aventis, Greece; Sanofi-Aventis, Italy; Sanofi-Aventis, Netherlands; Sanofi-Aventis - Produtos farmacêuticos, S.A., Portugal; Sanofi-Aventis S.A., Spain; Sanofi-Synthelabo, Luxembourg
- Danazol
AC Farma, Peru; GMP, Georgia; Jelfa, Poland; Lannett, United States; Polfarmex, Poland; Polfarmex, Serbia; Sanofi-Aventis, Netherlands
- Danocrine
Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Indonesia
- Danodiol
Remedica, Kenya; Remedica, Sudan; Remedica, Zimbabwe
- Danogen
Cipla, India; Cipla, Sri Lanka; Cipla, Vietnam; Cipla Medpro, South Africa; Pharmaceutical, Venezuela
- Danokrin
Sanofi-Aventis, Austria
- Danol
Sanofi-Aventis, Bahrain; Sanofi-Aventis, Egypt; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Georgia; Sanofi-Aventis, Ireland; Sanofi-Aventis, Israel; Sanofi-Aventis, Kuwait; Sanofi-Aventis, Lebanon; Sanofi-Aventis, Oman; Sanofi-Aventis, Qatar; Sanofi-Aventis, Saudi Arabia; Sanofi-Synthelabo, United Arab Emirates; Sanofi-Synthelabo, Cyprus; Sanofi-Synthelabo, Jordan
- Danol (veterinary use)
Sanofi-Synthelabo, United Kingdom
- Danoval
Krka, Croatia (Hrvatska); Krka, Hungary; Krka, Slovenia
- Dogalact (Danazol and Megestrol (veterinary use))
Laboratoire Vétoquinol, France
- Dogalact (veterinary use)
Vetoquinol, Luxembourg
- Dzol
Pacific, New Zealand
- Ectopal
Medochemie, Taiwan
- Esdelart
Nisshin Seiyaku - Yamagata, Japan
- Gonablok
Win-Medicare, Bangladesh; Win-Medicare, India
- Hosebon
Tatsumi Kagaku, Japan
- Ladazol
Adcock Ingram Pharmaceuticals, South Africa
- Ladogal
Sanofi-Aventis, Argentina; Sanofi-Aventis, Brazil; Sanofi-Aventis, Mexico; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Philippines; Sanofi-Aventis, Singapore; Sanofi-Aventis, Thailand; Sanofi-Aventis, Taiwan; Sanofi-Aventis, Venezuela
- Lozana
Incepta, Bangladesh
- Novaprin
Novag, Mexico
- Oyslon
Nagase Iyakuhin, Japan
- Zendol
Serum Institute, India
International Drug Name Search
Glossary
BAN | British Approved Name |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Prop.INN | Proposed International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and
International Nonproprietary Names.